Great Health Great Fitness

Experimental Drug Lepodisiran Marks Major Breakthrough in Genetic Heart-Disease Risk
A single dose reduces lipoprotein(a) by over 90% in large international trial In a landmark development for cardiovascular medicine, the…

A single dose reduces lipoprotein(a) by over 90% in large international trial In a landmark development for cardiovascular medicine, the…

Hospitals globally are moving from reactive care to proactive surveillance, using AI to predict outbreaks and patient deterioration Across multiple…

In a groundbreaking revelation that’s reshaping global health discussions, scientists have confirmed that as little as 15 minutes of daily…